CRISPR Therapeutics (CRSP STOCK): HUGE INSIDER BUY! 100% UPSIDE?

Profit Playbook
Profit Playbook
12 followers
Jul 24, 2025

Just yesterday Dr. Simeon George, a director of the board at CRISPR Therapeutics, disclosed investing over $50 million in CRSP stock at the market (around $52 per share). What does he see? Is there over 100% upside potential from here?